BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27618831)

  • 1. Clinical association of mixed connective tissue disease and granulomatosis with polyangiitis: a case report and systematic screening of anti-U1RNP and anti-PR3 auto-antibody double positivity in ten European hospitals.
    Tubery A; Fortenfant F; Combe B; Abreu I; Bossuyt X; Chretien P; Desplat-Jégo S; Fabien N; Hue S; Johanet C; Lakomy D; Vincent T; Daïen CI
    Immunol Res; 2016 Dec; 64(5-6):1243-1246. PubMed ID: 27618831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study.
    Ikeda S; Arita M; Misaki K; Kashiwagi Y; Ito Y; Yamada H; Hotta M; Nishiyama A; Ito A; Noyama M; Koyama T; Notohara K; Ishida T
    BMC Pulm Med; 2015 Jul; 15():78. PubMed ID: 26223225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.
    Granel J; Lemoine R; Morello E; Gallais Y; Mariot J; Drapeau M; Musnier A; Poupon A; Pugnière M; Seren S; Nouar D; Gouilleux-Gruart V; Watier H; Korkmaz B; Hoarau C
    Front Immunol; 2020; 11():573040. PubMed ID: 33101296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.
    Granel J; Korkmaz B; Nouar D; Weiss SAI; Jenne DE; Lemoine R; Hoarau C
    Front Immunol; 2021; 12():571933. PubMed ID: 33679731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.
    Clain JM; Hummel AM; Stone JH; Fervenza FC; Hoffman GS; Kallenberg CG; Langford CA; McCune WJ; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Ytterberg SR; Specks U;
    Clin Exp Immunol; 2017 Apr; 188(1):174-181. PubMed ID: 28076879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
    Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
    J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ detection of PR3-ANCA
    Weppner G; Ohlei O; Hammers CM; Holl-Ulrich K; Voswinkel J; Bischof J; Hasselbacher K; Riemekasten G; Lamprecht P; Ibrahim S; Iking-Konert C; Recke A; Müller A
    J Autoimmun; 2018 Sep; 93():89-103. PubMed ID: 30054207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry.
    Puéchal X; Iudici M; Pagnoux C; Cohen P; Hamidou M; Aouba A; Lifermann F; Ruivard M; Aumaître O; Bonnotte B; Maurier F; Le Gallou T; Hachulla E; Karras A; Khouatra C; Jourde-Chiche N; Viallard JF; Blanchard-Delaunay C; Godmer P; Le Quellec A; Quéméneur T; de Moreuil C; Mouthon L; Terrier B; Guillevin L;
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35296533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel strategy with combined assays for detection of anti-neutrophil cytoplasmic antibody (ANCA) in clinically ANCA-negative granulomatosis with polyangiitis patients.
    Tateyama K; Kodama S; Kishibe K; Harabuchi Y; Suzuki M
    Auris Nasus Larynx; 2017 Dec; 44(6):735-741. PubMed ID: 28666565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis.
    Land J; Abdulahad WH; Arends S; Sanders JF; Stegeman CA; Heeringa P; Rutgers A
    PLoS One; 2017; 12(8):e0182549. PubMed ID: 28771641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis.
    Hinkofer LC; Hummel AM; Stone JH; Hoffman GS; Merkel PA; Spiera ER; St Clair W; McCune JW; Davis JC; Specks U; Jenne DE
    J Autoimmun; 2015 May; 59():43-52. PubMed ID: 25744251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
    Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
    Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan.
    Ono N; Niiro H; Ueda A; Sawabe T; Nishizaka H; Furugo I; Yoshizawa S; Yoshizawa S; Tsukamoto H; Kiyohara C; Tada Y; Horiuchi T
    Rheumatol Int; 2015 Mar; 35(3):555-9. PubMed ID: 25129031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients.
    Thai LH; Charles P; Resche-Rigon M; Desseaux K; Guillevin L
    Autoimmun Rev; 2014 Mar; 13(3):313-8. PubMed ID: 24225075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice.
    Noel N; André C; Bengoufa D; Dehoulle C; Mahler M; Limal N; Godeau B; Hüe S
    Autoimmun Rev; 2013 Oct; 12(12):1118-22. PubMed ID: 23800447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular large B-cell lymphoma with a high titer of proteinase-3-anti-neutrophil cytoplasmic antibody mimicking granulomatosis with polyangiitis.
    Shinkawa Y; Hatachi S; Yagita M
    Mod Rheumatol; 2019 Jan; 29(1):195-197. PubMed ID: 27398728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should nasal biopsy inevitably be performed for classifying granulomatosis with polyangiitis in patients with rhinosinusitis? A retrospective chart review study.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Rheumatol Int; 2019 May; 39(5):885-892. PubMed ID: 30887162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis.
    Monti S; Felicetti M; Delvino P; Padoan R; Berti A; Paolazzi G; Brunori G; Schiavon F; Caporali R; Montecucco C
    Clin Exp Rheumatol; 2021; 39 Suppl 129(2):107-113. PubMed ID: 34014158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.